-
A prodrug of gabapentin has been approved by the FDA for the treatment of restless legs syndrome (RLS).
-
Let's make this simple: vitamin d deficiency causes EVERYTHING.
-
Physicians often do not choose the same clinical treatments for themselves as they would recommend to their patients.
-
A small study of the effects of acute cell phone use on brain glucose metabolism revealed significant increases in areas near the location of a phone's antenna. The findings do not imply that cell phone use causes brain damage, only that the electromagnetic fields from them do cause changes in brain function.
-
From 1985 to 2008, all first-ever strokes in the city of Dijon, France (150,000 inhabitants) were recorded, and among those patients who were testable (3201/3948 or 81%), 20.4% had post-stroke dementia.
-
In a large, randomized, controlled trial, screening for prostate cancer did not have a significant effect on mortality from prostate cancer after 20 years of follow-up.
-
The use of low-dose aspirin is associated with an almost two-fold increase in the risk of upper gastrointestinal bleeding compared with nonuse and this risk is further increased when low-dose aspirin is combined with clopidogrel, oral anticoagulants, nonsteroidal anti-inflammatory drugs, or high-dose oral corticosteroids.
-
A tyrosine kinase inhibitor has been approved for the treatment of medullary thyroid cancer (MTC).
-
-
Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
